Nano-X Imaging

History

2021: Purchase of AI Technology Developer for Medicine Zebra Medical Vision

On August 10, 2021, the sale of Zebra Medical Vision to Nano-X Imaging, which develops computer vision technologies in the health sector, was announced. The transaction amount will be about $200 million: the buyer will pay $100 million in advance and another $100 million in shares. More details here.

2020: Access to the Nasdaq Exchange

At the end of August 2020, Israeli startup Nano-X Imaging, specializing in digital radiography technologies, entered the exchange and raised $165.2 million during an initial public offering on the Nasdaq platform. By the end of the first day of trading, the company's capitalization amounted to almost $1 billion, despite the fact that it had not yet received regulatory permission to sell its tools.

On the first day of trading, the company began with a target price of $18 per share, and finished at $21.70. Nano-X believes its technology could "significantly reduce" the cost of medical imaging systems without compromising quality. Cheaper technology can increase the availability of screening and early diagnosis of diseases. At the same time, the integration of technology with the cloud system and the use of AI algorithms will provide professionals with the opportunity to establish the correct diagnosis in the shortest possible time.

Nano-X enters Nasdaq exchange

Nano-X was founded in 2018 and is developing a new type of X-ray radiation based on nanotechnology. The X-ray source developed by the company uses a new semiconductor cathode technique for a digital microelectromechanical system ("MEM"), which, according to the company, can provide the same functionality as traditional analog systems, while significantly reducing the cost of the procedure.

The system consists of a Nanox.ARC digital X-ray device and Nanox.Cloud cloud software. Provided that the company receives regulatory approval, the first version of Nanox.ARC will be a 3D tomosynthesis system. It is expected that the results of the system tests will be available in the third quarter of 2020, and the first devices will enter the market in the first quarter of 2021. The company hopes to install at least 1000 Nanox systems by the end of 2021, and by 2024 the company plans to deploy 15,000 Nanox systems.^[1]

Notes